K-V Pharmaceutical (KV-A) Reports Q4 Loss of $0.54/Share
Tweet
Share
E-mailGet Alerts KV-A Hot Sheet
Join SI Premium – FREE
K-V Pharmaceutical (NYSE: KV-A) reported Q4 EPS of ($0.54), versus ($3.04) reported last year.
For earnings history and earnings-related data on K-V Pharmaceutical (KV-A) click here.
For earnings history and earnings-related data on K-V Pharmaceutical (KV-A) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
- Omega Flex (OFLX) Tops Q2 EPS by 27c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
